Dimerix, EBR Systems, Island Pharmaceuticals and Optiscan have highlighted key clinical and commercial milestones in their latest quarterly results. ... Read More The post ASX Quarterly Health Wrap: ...

Before advances in scientific data storage and collaboration via the cloud, medical investigators seeking health research breakthroughs had to overcome significant obstacles to collaboration and the ...

University of Newcastle researchers have secured a total of more than $4 million to support three projects across biomedical, ...

Global Experts in MSC Clinical Translation to Advise Ebstrocel™ Regulatory and Clinical Development and Guide Expansion of CORDStrom Product ...

Cigarette smoking kills nearly half a million Americans each year, yet most people who smoke are unable to quit despite ...

COMO and CAPRI trials together rapidly enrolled over 480 participants in five months, demonstrating continued enthusiasm for DURAVYU trial ...

Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced the appointment of Howard H. Bailey, MD, as Chief Medical ...

Merck is the pharmaceutical company that makes a medication called pembrolizumab (Keytruda), which is used to treat different ...

A new AI tool could help predict which stage-two bowel cancer patients are at risk of relapse, in an advance that could ...

Dr Ruth Melia says clinicians must improve AI literacy as increasing amount of people turn to chatbots for help instead of in ...

IgA nephropathy is more likely to develop in men vs women. Ramy Hanna, MD, of University of California, Irvine, discussed why ...